🇪🇺EU · EMARefused

Horse Allo 20(allogeneic equine adipose-derived mesenchymal stem cells)

Marketing Authorisation Holder: Centauri Biotech SL

INN: allogeneic equine adipose-derived mesenchymal stem cells

Indication

For the treatment osteoarthritis in adult non-food producing horses.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Horse Allo 20 — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about Horse Allo 20 Create Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.